BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 29284070)

  • 1. Evaluation of fluorescence-guided surgery agents in a murine model of soft tissue fibrosarcoma.
    Prince AC; McGee AS; Siegel H; Rosenthal EL; Behnke NK; Warram JM
    J Surg Oncol; 2018 May; 117(6):1179-1187. PubMed ID: 29284070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of optical imaging agents in a fluorescence-guided surgical model of head and neck cancer.
    Prince AC; Moore LS; Tipirneni KE; Ramesh T; Limdi MA; Bevans SL; Walsh EM; Greene B; Rosenthal EL; Warram JM
    Surg Oncol; 2018 Jun; 27(2):225-230. PubMed ID: 29937175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Panitumumab-IRDye800CW for Fluorescence-Guided Surgical Resection of Colorectal Cancer.
    Marston JC; Kennedy GD; Lapi SE; Hartman YE; Richardson MT; Modi HM; Warram JM
    J Surg Res; 2019 Jul; 239():44-51. PubMed ID: 30798171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal Dosing Strategy for Fluorescence-Guided Surgery with Panitumumab-IRDye800CW in Head and Neck Cancer.
    Nishio N; van den Berg NS; van Keulen S; Martin BA; Fakurnejad S; Zhou Q; Lu G; Chirita SU; Kaplan MJ; Divi V; Colevas AD; Rosenthal EL
    Mol Imaging Biol; 2020 Feb; 22(1):156-164. PubMed ID: 31054001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting tumors with a killer-reporter adenovirus for curative fluorescence-guided surgery of soft-tissue sarcoma.
    Yano S; Miwa S; Kishimoto H; Uehara F; Tazawa H; Toneri M; Hiroshima Y; Yamamoto M; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
    Oncotarget; 2015 May; 6(15):13133-48. PubMed ID: 26033451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW.
    Warram JM; de Boer E; Korb M; Hartman Y; Kovar J; Markert JM; Gillespie GY; Rosenthal EL
    Br J Neurosurg; 2015; 29(6):850-8. PubMed ID: 26073144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved resection and prolonged overall survival with PD-1-IRDye800CW fluorescence probe-guided surgery and PD-1 adjuvant immunotherapy in 4T1 mouse model.
    Du Y; Sun T; Liang X; Li Y; Jin Z; Xue H; Wan Y; Tian J
    Int J Nanomedicine; 2017; 12():8337-8351. PubMed ID: 29200846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescence-guided surgery of retroperitoneal-implanted human fibrosarcoma in nude mice delays or eliminates tumor recurrence and increases survival compared to bright-light surgery.
    Uehara F; Hiroshima Y; Miwa S; Tome Y; Yano S; Yamamoto M; Matsumoto Y; Maehara H; Tanaka K; Bouvet M; Kanaya F; Hoffman RM
    PLoS One; 2015; 10(2):e0116865. PubMed ID: 25710463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a Novel Histone Deacetylase-Targeted Near-Infrared Probe for Hepatocellular Carcinoma Imaging and Fluorescence Image-Guided Surgery.
    Tang C; Du Y; Liang Q; Cheng Z; Tian J
    Mol Imaging Biol; 2020 Jun; 22(3):476-485. PubMed ID: 31228075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-in-human study of PET and optical dual-modality image-guided surgery in glioblastoma using
    Li D; Zhang J; Chi C; Xiao X; Wang J; Lang L; Ali I; Niu G; Zhang L; Tian J; Ji N; Zhu Z; Chen X
    Theranostics; 2018; 8(9):2508-2520. PubMed ID: 29721096
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterizing the detection threshold for optical imaging in surgical oncology.
    Prince AC; Jani A; Korb M; Tipirneni KE; Kasten BB; Rosenthal EL; Warram JM
    J Surg Oncol; 2017 Dec; 116(7):898-906. PubMed ID: 28628728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical comparison of near-infrared-labeled cetuximab and panitumumab for optical imaging of head and neck squamous cell carcinoma.
    Day KE; Sweeny L; Kulbersh B; Zinn KR; Rosenthal EL
    Mol Imaging Biol; 2013 Dec; 15(6):722-9. PubMed ID: 23715932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-in-human intraoperative near-infrared fluorescence imaging of glioblastoma using cetuximab-IRDye800.
    Miller SE; Tummers WS; Teraphongphom N; van den Berg NS; Hasan A; Ertsey RD; Nagpal S; Recht LD; Plowey ED; Vogel H; Harsh GR; Grant GA; Li GH; Rosenthal EL
    J Neurooncol; 2018 Aug; 139(1):135-143. PubMed ID: 29623552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic Fluorescence-Guided Surgery for Sinonasal Cancer Using an Antibody-Dye Conjugate.
    Hart ZP; Nishio N; Krishnan G; Lu G; Zhou Q; Fakurnejad S; Wormald PJ; van den Berg NS; Rosenthal EL; Baik FM
    Laryngoscope; 2020 Dec; 130(12):2811-2817. PubMed ID: 31854462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of an Unlabeled Loading Dose on Tumor-Specific Uptake of a Fluorescently Labeled Antibody for Optical Surgical Navigation.
    Moore LS; Rosenthal EL; de Boer E; Prince AC; Patel N; Richman JM; Morlandt AB; Carroll WR; Zinn KR; Warram JM
    Mol Imaging Biol; 2017 Aug; 19(4):610-616. PubMed ID: 27830425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved Intraoperative Detection of Ovarian Cancer by Folate Receptor Alpha Targeted Dual-Modality Imaging.
    Hekman MCH; Boerman OC; Bos DL; Massuger LFAG; Weil S; Grasso L; Rybinski KA; Oosterwijk E; Mulders PFA; Rijpkema M
    Mol Pharm; 2017 Oct; 14(10):3457-3463. PubMed ID: 28826214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optical Imaging of Renal Cell Carcinoma with Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab.
    Muselaers CH; Stillebroer AB; Rijpkema M; Franssen GM; Oosterwijk E; Mulders PF; Oyen WJ; Boerman OC
    J Nucl Med; 2014 Jun; 55(6):1035-40. PubMed ID: 24752673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multimodal molecular imaging approach targeting urokinase plasminogen activator receptor for the diagnosis, resection and surveillance of urothelial cell carcinoma.
    Baart VM; van der Horst G; Deken MM; Bhairosingh SS; Schomann T; Sier VQ; van der Mark MH; Iamele L; de Jonge H; Resnati M; Mazar AP; Pelger RCM; van der Pluijm G; Kuppen PJK; Vahrmeijer AL; Sier CFM
    Eur J Cancer; 2021 Mar; 146():11-20. PubMed ID: 33561783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of Tumor Margins with Surgical Specimen Mapping Using Near-Infrared Fluorescence.
    Gao RW; Teraphongphom NT; van den Berg NS; Martin BA; Oberhelman NJ; Divi V; Kaplan MJ; Hong SS; Lu G; Ertsey R; Tummers WSFJ; Gomez AJ; Holsinger FC; Kong CS; Colevas AD; Warram JM; Rosenthal EL
    Cancer Res; 2018 Sep; 78(17):5144-5154. PubMed ID: 29967260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence- and multispectral optoacoustic imaging for an optimized detection of deeply located tumors in an orthotopic mouse model of pancreatic carcinoma.
    Napp J; Stammes MA; Claussen J; Prevoo HAJM; Sier CFM; Hoeben FJM; Robillard MS; Vahrmeijer AL; Devling T; Chan AB; de Geus-Oei LF; Alves F
    Int J Cancer; 2018 May; 142(10):2118-2129. PubMed ID: 29277891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.